Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

LEI105

Inquiry
Cat. No.: OB0425LY-041
Synonyms: 1800327-36-9; 1-[6-(4-Methylphenyl)-[1,3]oxazolo[4,5-b]pyridin-2-yl]-6-phenylhexan-1-one; 6-Phenyl-1-(6-(p-tolyl)oxazolo[4,5-b]pyridin-2-yl)hexan-1-; 6-Phenyl-1-(6-(p-tolyl)oxazolo[4,5-b]pyridin-2-yl)hexan-1- one
Size: 50 mg; 100 mg; 250 mg
CAS No.: 1800327-36-9
Compound CID: 122390213
LEI105

Specification

Description: LEI105 is an active and highly selective dual diacylglycerol lipase (DAGL)-α/DAGL-β inhibitor.
Formula Weight: 384.47
Applications: LEI105 is primarily used in inflammation, metabolic diseases and some cancer research.
Storage: Storage at -20°C.
Formula: C25H24N2O2
Appearance: Solid
Purity: ≥95%
Pathway: Metabolic enzyme/Protease
Target: DAGL

Library Information

Inquiry

Copyright © Protheragen. All rights reserves.